Application 071483
- Type
- ANDA
- Sponsor
- MYLAN
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | TABLET;ORAL | 120MG | No | No |
| 002 | VERAPAMIL HYDROCHLORIDE | VERAPAMIL HYDROCHLORIDE | TABLET;ORAL | 80MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0378-0512 | Verapamil Hydrochloride | verapamil hydrochloride | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-0512 | Verapamil Hydrochloride | verapamil hydrochloride | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-0772 | Verapamil Hydrochloride | verapamil hydrochloride | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 0378-0772 | Verapamil Hydrochloride | verapamil hydrochloride | Mylan Pharmaceuticals Inc. | ANDA | Current |
| 55289-481 | Verapamil Hydrochloride | verapamil hydrochloride | PD-Rx Pharmaceuticals, Inc. | ANDA | Current |